Diabetic neuropathy: Achieving best practice

British Journal of Diabetes and Vascular Disease

Volumn 3, Issue 2, 2003, Pages 112-117

  Tesfaye, Solomon ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Diabetes; Diabetic foot; Diabetic neuropathy; Neuropathy; Painful neuropathy; Peripheral neuropathy

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; CAPSAICIN; CARBAMAZEPINE; GABAPENTIN; IMIPRAMINE; INSULIN; LIDOCAINE; MEXILETINE; MORPHINE; OPIATE; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; THIOCTIC ACID; TRICYCLIC ANTIDEPRESSANT AGENT;

ANAMNESIS; ARTICLE; ATAXIA; AUTONOMIC NEUROPATHY; CLINICAL EXAMINATION; CLINICAL FEATURE; DEVELOPED COUNTRY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DROWSINESS; FOOT ULCER; GOOD CLINICAL PRACTICE; HUMAN; MONONEUROPATHY; MUSCLE ATROPHY; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; PARALYSIS; PERIPHERAL NEUROPATHY; QUALITY OF LIFE; RADICULOPATHY; SOMNOLENCE; SPINAL CORD STIMULATION; TRANSCUTANEOUS NERVE STIMULATION; VERTIGO; XEROSTOMIA;

EID: 0041360099     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/14746514030030020601     Document Type: Article

References (55)

1. Tesfaye S, Stephens L, Stephenson J et al. The prevalence of diabetic neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996;39:1377-84.
2. Tesfaye S. Diabetic neuropathy. In: Wass JAH, Shallet SM (eds.). Oxford Textbook of Endocrinology. Oxford: Oxford University Press, 2002:1789-98.
3. Watkins PJ, Edmonds ME. Clinical features of diabetic neuropathy. In: Pickup J, Williams G (eds.). Textbook of Diabetes Vol. 2. Oxford: Blackwell Science, 1997;50.1-50.20.
4. Tesfaye S, Price D. Therapeutic approaches in diabetic neuropathy and neuropathic pain. In: Boulton AJM (ed.). Diabetic Neuropathy. Carnforth: Marius Press, 1997:159-5.
5. Ewing DJ, Borsey DQ, Bellavere F, Clarke BF Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation. Diabetologia 1981;21:18-24.
6. Andersen H, Jakobsen J. Motor function in diabetes. Diabetes Reviews 1999;7:326-41.
7. Eaton SE, Harris ND, Rajbhandari SM et al. Spinal-cord involvement in diabetic neuropathy. Lancet 2001;358:35-6.
8. Chan AW, MacFarlane IA, Bowsher DR, Wells JC, Bessex C, Griffiths K. Chronic pain in patients with diabetes mellitus: comparison with non-diabetic population. Pain Clin 1990;3:147-59.
9. Watkins PJ. Pain and diabetic neuropathy. BMJ 1984;288:168-9.
10. Tesfaye S, Ward JD. Clinical features of diabetic polyneuropathy. In: Veves A, (ed.). Clinical Management of Diabetic Neuropathy. Totowa NJ: Humana Press, 1998:49-60.
11. Tesfaye S, Watt J, Benbow SJ, Pang KA, Miles J, MacFarlane IA. Electrical spinal cord stimulation for painful diabetic peripheral neuropathy. Lancet 1996;348:1696-701.
12. Boulton AJM. Foot problems in patients with diabetes mellitus. In: Pickup J, Williams G (eds.). Textbook of Diabetes Vol 2. Oxford: Blackwell Science, 1997:58.1-58.20.
13. Ward JD. The diabetic leg. Diabetologia 1982;22:141-7.
14. Ward JD, Simms JM, Knight G, Boulton AJM, Sandler DA. Venous distension in the diabetic neuropathic foot (physical sign of arterio-venous shunting). J Roy Soc Med 1983;76:1011-14.
15. Rajbhandari SM, Jenkins R, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia, 2002;45:1085-96.
16. Caravati CM. Insulin neuritis: a case report. Va Med Mon 1933;59:745-6.
17. Tesfaye S, Malik R, Harris N et al. Arteriovenous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 1996;39:329-35.
18. Archer AG, Watkins PJ, Thomas PJ, Sharma AK, Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neorosurg Psychiatry 1983;46:491-6.
19. Boulton AJM, Armstrong WD, Scarpello JHB, Ward JD. The natural history of painful diabetic neuropathy - a 4 year study. Postgrad Med J 1983;59:556-9.
20. Benbow SJ, Chan AW, Bowsher D, McFarlane IA, Williams G. A prospective study of painful symptoms, small fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabet Med 1994; 11:17-21.
21. Tesfaye S, Harris N, Wilson RM, Ward JD. Exercise induced conduction velocity increment: a marker of impaired nerve blood flow in diabetic neuropathy. Diabetologia 1992;35:155-9.
22. Bastron JA, Thomas JE. Diabetic polyradiculoneuropathy: clinical and electromyographic findings in 105 patients. Mayo Clinic Proc 1981;56: 725-32.
23. Ellenberg M. Diabetic neuropathic cachexia. Diabetes 1974;23:418-23.
24. Guy RJC, Clark CA, Malcolm PN, Watkins PJ. Evaluation of thermal and vibration sensation in diabetic neuropathy. Diabetologia 1985;28:131.
25. Eaton SEM, Tesfaye S. Clinical manifestations and measurement of somatic neuropathy. Diabetes Reviews 1999;7:312-25.
26. Clements RS, Bell DSH. Diagnostic, pathogenic and therapeutic aspects of diabetic neuropathy. Special Topics Endocrinol Metab 1982;3:1-43.
27. Matikainen E, Juntunen J. Diabetic neuropathy: Epidemiological, pathogenetic, and clinical aspects with special emphasis on type 2 diabetes mellitus. Acta Endocrinol Suppl (Copenh) 1984;262:89-94.
28. Garland H. Diabetic amyotrophy. BMJ 1955;2:1287-90.
29. Coppack SW, Watkins PJ. The natural history of femoral neuropathy. QJ Med 1991;79:307-13.
30. Casey EB, Harrison MJG. Diabetic amyotrophy: a follow-up study. BMJ 1972;1:656.
31. Garland H, Taverner D. Diabetic myelopathy. BMJ 1953;1:1405.
32. Subramony SH, Willbourn AJ. Diabetic proximal neuropathy. Clinical and electromyographic studies. J Neurol Sci 1982;53:293-304.
33. Ward JD. Clinical features of diabetic neuropathy. In: Ward JD, Goto Y, (eds.). Diabetic Neuropathy. Chichester, UK: Wiley, 1990:281-96.
34. Leslie RDG, Ellis C. Clinical course following diabetic ocular palsy. Postgrad Med J 1978;54:791-2.
35. Asbury AK, Aldredge H, Hershberg R, Fisher CM. Oculomotor palsy in diabetes mellitus: a clinicopathological study. Brain 1970;93:555-7.
36. Zorilla E, Kozak GP. Ophthalmoplegia in diabetes mellitus. Annals of Internal Medicine 1967;67:968-76.
37. Goldstein JE, Cogan DG. Diabetic ophthalmoplegia with special reference to the pupil. Arch Ophthalmol 1960;64:592-600.
38. Ellenberg M. Diabetic truncal mononeuropathy - a new clinical syndrome. Diabetes Care 1978;1:10-13.
39. Boulton AJM, Angus E, Ayyar DR, Weiss R. Diabetic thoracic polyradiculopathy presenting as abdominal swelling. BMJ 1984;289:798-9.
40. Dyck PJ, Kratz KM, Karnes JL et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-24.
41. Clayburgh RH, Beckenbaugh RD, Dobyns JH. Carpal tunnel release in patients with diffuse peripheral neuropathy. J Hand Surg 1987;12A:380-3.
42. White JES, Bullock RF, Hudgson P, Home PD, Gibson G.J. Phrenic neuropathy in association with diabetes. Diabet Med 1992;9:954-6.
43. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Int Med 1995;122:561-8.
44. United Kingdom Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-53.
45. Boulton AJM, Drury J, Clarke B, Ward JD. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 1982;5:386-90.
46. Max MB, Culnane M, Schafer SC et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37:589-96.
47. Sindrup SH, Grodum E, Gram LF, Beck-Nielsen H. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Ther Drug Monit 1991;13:408-14.
48. Davis JL. Use of sibutramine hydrochloride monohydrate in the treatment of the painful peripheral neuropathy of diabetes. Diabetes Care 2000; 23:1594.
49. Rull J, Quibrera R, Gonzalez-Millan H, Lozano Castenada O. Symptomatic treatment of peripheral neuropathy with carbamazepine (Tegretol). Diabetologia 1969;5:215-18.
50. Chadda VS, Mathur MS. Double blind study of the effects of diphenylhydrantoin sodium on diabetic neuropathy. J Assoc Physicians India 1978;26:403-06.
51. Backonja M, Beydoun A, Edwards KR et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomised controlled trial. JAMA 1998;280:1831-6.
52. Kastrup J, Angelo H, Petersen P, Dejgard A, Hilsted J. Treatment of chronic painful neuropathy with intravenous lidocaine infusion. BMJ 1986;292:173.
53. Capsaicin Study Group. The effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 1992;15:159-65.
54. Zeigler D, Hanefeld M, Ruhnau KJ et al. Treatment of symptomatic diabetic peripheral neuropathy with anti-oxidant alpha-lipoic acid: a 3-week multicentre randomised controlled trial (ALADIN Study). Diabetologia 1995;38:1425-33.
55. Harati Y, Gooch C, Swenson M et al. Double-blind randomised trial of tramadol for the treatment of the pain of diabetic neuropathy. Neuropathy 1998;50:1842-6.